Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy.
作者信息
Kelmser Ethan C, Parekh Anya, LaVasseur Corinne, Svetec Sarah, Alex Jacob, Berkowitz Jake, McCarty Owen J T, Shatzel Joseph J, Chalker Cameron, Nakayama Karina H
机构信息
Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon, USA.
Division of Hematology/Oncology, University of California Davis, Davis, California, USA.
出版信息
Res Pract Thromb Haemost. 2025 May 17;9(4):102884. doi: 10.1016/j.rpth.2025.102884. eCollection 2025 May.
Abstract
摘要
相似文献
1
Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy.接受雌激素类激素治疗的变性患者术后静脉血栓栓塞
Res Pract Thromb Haemost. 2025 May 17;9(4):102884. doi: 10.1016/j.rpth.2025.102884. eCollection 2025 May.
2
Risk of venous thromboembolism in the transgender population on hormone therapy: A systematic review.接受激素治疗的跨性别者发生静脉血栓栓塞的风险：一项系统评价。
Med Clin (Barc). 2025 Jun 27;164(12):106921. doi: 10.1016/j.medcli.2025.106921. Epub 2025 Apr 17.
3
Review of venous thromboembolism (VTE) risk, evaluation, and treatment in individuals on estrogen-based gender-affirming hormone therapy.基于雌激素的性别确认激素治疗个体的静脉血栓栓塞（VTE）风险、评估及治疗综述
Vasc Med. 2025 Aug;30(4):488-498. doi: 10.1177/1358863X251334141. Epub 2025 May 14.
4
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.管理接受激素治疗的成年跨性别者静脉血栓栓塞的风险。
J Blood Med. 2019 Jul 10;10:209-216. doi: 10.2147/JBM.S166780. eCollection 2019.
5
Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.跨性别患者在接受跨性别激素治疗时发生静脉血栓栓塞的风险：系统评价。
J Sex Med. 2021 Jul;18(7):1280-1291. doi: 10.1016/j.jsxm.2021.04.006. Epub 2021 Jun 16.
6
Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.雌激素激素治疗的给药途径是否会影响静脉血栓栓塞的风险？雌二醇透皮系统与口服单纯雌激素激素治疗。
Menopause. 2018 Nov;25(11):1297-1305. doi: 10.1097/GME.0000000000001232.
7
Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.雌激素激素治疗的给药途径是否会影响静脉血栓栓塞的风险？雌二醇透皮系统与口服仅雌激素激素治疗。
Menopause. 2011 Oct;18(10):1052-9. doi: 10.1097/gme.0b013e3182175e5c.
8
Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications.围手术期跨性别激素管理：避免静脉血栓栓塞和其他并发症。
Plast Reconstr Surg. 2021 Apr 1;147(4):1008-1017. doi: 10.1097/PRS.0000000000007786.
9
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.跨性别者接受激素 feminizing 治疗后的静脉血栓栓塞风险：一项患病率的荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2021 Nov 9;12:741866. doi: 10.3389/fendo.2021.741866. eCollection 2021.
10
Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.静脉血栓栓塞症与含雌激素的性别肯定激素治疗。
Thromb Haemost. 2024 May;124(5):387-398. doi: 10.1055/a-2188-8898. Epub 2023 Oct 10.
本文引用的文献
1
National Estimates of Gender-Affirming Surgery in the US.美国的性别肯定手术的国家估计数。
JAMA Netw Open. 2023 Aug 1;6(8):e2330348. doi: 10.1001/jamanetworkopen.2023.30348.
2
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
3
Hormonal therapies and venous thrombosis: Considerations for prevention and management.激素疗法与静脉血栓形成：预防与管理的考量
Res Pract Thromb Haemost. 2022 Aug 23;6(6):e12763. doi: 10.1002/rth2.12763. eCollection 2022 Aug.
4
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.跨性别者接受激素 feminizing 治疗后的静脉血栓栓塞风险：一项患病率的荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2021 Nov 9;12:741866. doi: 10.3389/fendo.2021.741866. eCollection 2021.
5
Minimizing Venous Thromboembolism in Feminizing Hormone Therapy: Applying Lessons From Cisgender Women and Previous Data.最小化女性激素治疗中的静脉血栓栓塞：借鉴顺性别女性和既往数据的经验。
Endocr Pract. 2021 Jun;27(6):621-625. doi: 10.1016/j.eprac.2021.03.010. Epub 2021 Apr 2.
6
Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population.跨性别群体中的心血管疾病风险因素与心肌梗死
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005597. doi: 10.1161/CIRCOUTCOMES.119.005597.
7
Thrombotic issues in transgender medicine: A review. transgender 医学中的血栓问题：综述。
Am J Hematol. 2017 Feb;92(2):204-208. doi: 10.1002/ajh.24593.
8
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.接受口服雌二醇治疗的跨性别女性静脉血栓栓塞的发生率。
J Sex Med. 2016 Nov;13(11):1773-1777. doi: 10.1016/j.jsxm.2016.09.001. Epub 2016 Sep 23.
9
Endogenous sex hormones and risk of venous thromboembolism in women and men.内源性性激素与女性和男性静脉血栓栓塞风险。
J Thromb Haemost. 2014;12(3):297-305. doi: 10.1111/jth.12484.
10
Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.激素治疗可减少性别认同障碍患者的心理生物学困扰，而与依恋类型无关。
J Sex Med. 2013 Dec;10(12):3049-58. doi: 10.1111/jsm.12155. Epub 2013 Apr 9.
Zotero 插件